Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors.

NeuroImage

Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan TO, Rusinek H, Scharre D, Sperling R, Weiner MW, Green RC.
PMID: 22100665
Neuroimage. 2012 Feb 15;59(4):4196-200. doi: 10.1016/j.neuroimage.2011.10.085. Epub 2011 Nov 04.

An efficient approach to certain types of biomedical research requires a scale that precludes involvement of all critical contributors in all aspects of experimental design, execution, and as well as writing of most, if not all, derived works. Guarantors...

Cite
Hurko O, Black SE, Doody R, et al. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2011;59(4):4196-200doi: 10.1016/j.neuroimage.2011.10.085.
Hurko, O., Black, S. E., Doody, R., Doraiswamy, P. M., Gamst, A., Kaye, J., Obisesan, T. O., Rusinek, H., Scharre, D., Sperling, R., Weiner, M. W., Green, R. C. (2012). The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. NeuroImage, 59(4), 4196-200. https://doi.org/10.1016/j.neuroimage.2011.10.085
Hurko, Orest, et al. "The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors." NeuroImage vol. 59,4 (2012): 4196-200. doi: https://doi.org/10.1016/j.neuroimage.2011.10.085
Hurko O, Black SE, Doody R, Doraiswamy PM, Gamst A, Kaye J, Obisesan TO, Rusinek H, Scharre D, Sperling R, Weiner MW, Green RC. The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage. 2012 Feb 15;59(4):4196-200. doi: 10.1016/j.neuroimage.2011.10.085. Epub 2011 Nov 04. PMID: 22100665; PMCID: PMC3676932.
Copy Download .nbib Format: NLM
Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.

JAMA network open

Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JD.
PMID: 34228129
JAMA Netw Open. 2021 Jul 01;4(7):e2114364. doi: 10.1001/jamanetworkopen.2021.14364.

IMPORTANCE: Underrepresentation of many racial/ethnic groups in Alzheimer disease (AD) clinical trials limits generalizability of results and hinders opportunities to examine potential effect modification of candidate treatments.OBJECTIVE: To examine racial and ethnic differences in recruitment methods and trial eligibility...

Cite
Raman R, Quiroz YT, Langford O, et al. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA Netw Open. 2021;4(7):e2114364doi: 10.1001/jamanetworkopen.2021.14364.
Raman, R., Quiroz, Y. T., Langford, O., Choi, J., Ritchie, M., Baumgartner, M., Rentz, D., Aggarwal, N. T., Aisen, P., Sperling, R., & Grill, J. D. (2021). Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA network open, 4(7), e2114364. https://doi.org/10.1001/jamanetworkopen.2021.14364
Raman, Rema, et al. "Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial." JAMA network open vol. 4,7 (2021): e2114364. doi: https://doi.org/10.1001/jamanetworkopen.2021.14364
Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JD. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. JAMA Netw Open. 2021 Jul 01;4(7):e2114364. doi: 10.1001/jamanetworkopen.2021.14364. PMID: 34228129; PMCID: PMC8261604.
Copy Download .nbib Format: NLM
Amyloid-associated increases in longitudinal report of subjective cognitive complaints.

Alzheimer's & dementia (New York, N. Y.)

Amariglio RE, Buckley RF, Mormino EC, Marshall GA, Johnson KA, Rentz DM, Sperling RA.
PMID: 30258973
Alzheimers Dement (N Y). 2018 Sep 06;4:444-449. doi: 10.1016/j.trci.2018.08.005. eCollection 2018.

INTRODUCTION: To investigate whether baseline subjective cognitive complaints (SCCs) predict longitudinal decline on neuropsychological testing and whether SCC increases longitudinally, in the setting of high levels of amyloid burden.METHODS: Two hundred seventy-nine clinically normal older participants (mean age =...

Cite
Amariglio RE, Buckley RF, Mormino EC, et al. Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimers Dement (N Y). 2018;4:444-449doi: 10.1016/j.trci.2018.08.005.
Amariglio, R. E., Buckley, R. F., Mormino, E. C., Marshall, G. A., Johnson, K. A., Rentz, D. M., & Sperling, R. A. (2018). Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimer's & dementia (New York, N. Y.), 4444-449. https://doi.org/10.1016/j.trci.2018.08.005
Amariglio, Rebecca E, et al. "Amyloid-associated increases in longitudinal report of subjective cognitive complaints." Alzheimer's & dementia (New York, N. Y.) vol. 4 (2018): 444-449. doi: https://doi.org/10.1016/j.trci.2018.08.005
Amariglio RE, Buckley RF, Mormino EC, Marshall GA, Johnson KA, Rentz DM, Sperling RA. Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimers Dement (N Y). 2018 Sep 06;4:444-449. doi: 10.1016/j.trci.2018.08.005. eCollection 2018. PMID: 30258973; PMCID: PMC6153378.
Copy Download .nbib Format: NLM
Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly.

The journal of prevention of Alzheimer's disease

Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM.
PMID: 29124043
J Prev Alzheimers Dis. 2017;4(2):81-86. doi: 10.14283/jpad.2017.10.

BACKGROUND: Impairment in activities of daily living is a major burden to both patients and caregivers. Mild impairment in instrumental activities of daily living is often seen at the stage of mild cognitive impairment. The field of Alzheimer's disease...

Cite
Marshall GA, Aghjayan SL, Dekhtyar M, et al. Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. J Prev Alzheimers Dis. 2017;4(2):81-86doi: 10.14283/jpad.2017.10.
Marshall, G. A., Aghjayan, S. L., Dekhtyar, M., Locascio, J. J., Jethwani, K., Amariglio, R. E., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2017). Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. The journal of prevention of Alzheimer's disease, 4(2), 81-86. https://doi.org/10.14283/jpad.2017.10
Marshall, Gad A, et al. "Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly." The journal of prevention of Alzheimer's disease vol. 4,2 (2017): 81-86. doi: https://doi.org/10.14283/jpad.2017.10
Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM. Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. J Prev Alzheimers Dis. 2017;4(2):81-86. doi: 10.14283/jpad.2017.10. PMID: 29124043; PMCID: PMC5675571.
Copy Download .nbib Format: NLM
The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease.

The journal of prevention of Alzheimer's disease

Marshall GA, Dekhtyar M, Bruno JM, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM.
PMID: 26665121
J Prev Alzheimers Dis. 2015 Dec;2(4):242-253. doi: 10.14283/jpad.2015.72.

BACKGROUND: Impairment in activities of daily living is a major burden for Alzheimer's disease dementia patients and caregivers. Multiple subjective scales and a few performance-based instruments have been validated and proven to be reliable in measuring instrumental activities of...

Cite
Marshall GA, Dekhtyar M, Bruno JM, et al. The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. J Prev Alzheimers Dis. 2015;2(4):242-253doi: 10.14283/jpad.2015.72.
Marshall, G. A., Dekhtyar, M., Bruno, J. M., Jethwani, K., Amariglio, R. E., Johnson, K. A., Sperling, R. A., & Rentz, D. M. (2015). The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. The journal of prevention of Alzheimer's disease, 2(4), 242-253. https://doi.org/10.14283/jpad.2015.72
Marshall, Gad A, et al. "The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease." The journal of prevention of Alzheimer's disease vol. 2,4 (2015): 242-253. doi: https://doi.org/10.14283/jpad.2015.72
Marshall GA, Dekhtyar M, Bruno JM, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM. The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. J Prev Alzheimers Dis. 2015 Dec;2(4):242-253. doi: 10.14283/jpad.2015.72. PMID: 26665121; PMCID: PMC4671513.
Copy Download .nbib Format: NLM
Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)

Samaroo A, Amariglio RE, Burnham S, Sparks P, Properzi M, Schultz AP, Buckley R, Johnson KA, Sperling RA, Rentz DM, Papp KV.
PMID: 33426266
Alzheimers Dement (Amst). 2021 Jan 05;12(1):e12132. doi: 10.1002/dad2.12132. eCollection 2020.

INTRODUCTION: We determine whether diminished Learning Over Repeated Exposures (LORE) identifies subtle memory decrements in cognitively unimpaired (CU) older adults with Alzheimer's disease (AD) biomarker burden.METHODS: Ninety-four CU participants (mean age = 77.6 ± 5.02) completed a challenging associative...

Cite
Samaroo A, Amariglio RE, Burnham S, et al. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2021;12(1):e12132doi: 10.1002/dad2.12132.
Samaroo, A., Amariglio, R. E., Burnham, S., Sparks, P., Properzi, M., Schultz, A. P., Buckley, R., Johnson, K. A., Sperling, R. A., Rentz, D. M., & Papp, K. V. (2020). Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 12(1), e12132. https://doi.org/10.1002/dad2.12132
Samaroo, Aubryn, et al. "Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 12,1 (2020): e12132. doi: https://doi.org/10.1002/dad2.12132
Samaroo A, Amariglio RE, Burnham S, Sparks P, Properzi M, Schultz AP, Buckley R, Johnson KA, Sperling RA, Rentz DM, Papp KV. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease. Alzheimers Dement (Amst). 2021 Jan 05;12(1):e12132. doi: 10.1002/dad2.12132. eCollection 2020. PMID: 33426266; PMCID: PMC7784542.
Copy Download .nbib Format: NLM
Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, Pruzin JJ, Fitzpatrick CD, Yau WW, Kirn DR, Rentz DM, Arnold SE, Johnson KA, Sperling RA, Chhatwal JP, Tanzi RE.
PMID: 34160128
Alzheimers Dement. 2021 Jun 23; doi: 10.1002/alz.12399. Epub 2021 Jun 23.

INTRODUCTION: Immune dysregulation is implicated in neurodegeneration and altered cytokine levels are seen in people with dementia. However, whether cytokine levels are predictive of cognitive decline in cognitively unimpaired (CU) elderly, especially in the setting of elevated amyloid beta...

Cite
Yang HS, Zhang C, Carlyle BC, et al. Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2021;doi: 10.1002/alz.12399.
Yang, H. S., Zhang, C., Carlyle, B. C., Zhen, S. Y., Trombetta, B. A., Schultz, A. P., Pruzin, J. J., Fitzpatrick, C. D., Yau, W. W., Kirn, D. R., Rentz, D. M., Arnold, S. E., Johnson, K. A., Sperling, R. A., Chhatwal, J. P., & Tanzi, R. E. (2021). Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12399
Yang, Hyun-Sik, et al. "Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12399
Yang HS, Zhang C, Carlyle BC, Zhen SY, Trombetta BA, Schultz AP, Pruzin JJ, Fitzpatrick CD, Yau WW, Kirn DR, Rentz DM, Arnold SE, Johnson KA, Sperling RA, Chhatwal JP, Tanzi RE. Plasma IL-12/IFN-γ axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2021 Jun 23; doi: 10.1002/alz.12399. Epub 2021 Jun 23. PMID: 34160128; PMCID: PMC8695625.
Copy Download .nbib Format: NLM
Cardiorespiratory fitness is associated with white matter integrity in aging.

Annals of clinical and translational neurology

Hayes SM, Salat DH, Forman DE, Sperling RA, Verfaellie M.
PMID: 26125043
Ann Clin Transl Neurol. 2015 Jun;2(6):688-98. doi: 10.1002/acn3.204. Epub 2015 Apr 24.

OBJECTIVE: Aging is associated with reduced neural integrity, yet there are remarkable individual differences in brain health among older adults (OA). One factor that may attenuate age-related neural decline is cardiorespiratory fitness (CRF). The primary aim of this study...

Cite
Hayes SM, Salat DH, Forman DE, et al. Cardiorespiratory fitness is associated with white matter integrity in aging. Ann Clin Transl Neurol. 2015;2(6):688-98doi: 10.1002/acn3.204.
Hayes, S. M., Salat, D. H., Forman, D. E., Sperling, R. A., & Verfaellie, M. (2015). Cardiorespiratory fitness is associated with white matter integrity in aging. Annals of clinical and translational neurology, 2(6), 688-98. https://doi.org/10.1002/acn3.204
Hayes, Scott M, et al. "Cardiorespiratory fitness is associated with white matter integrity in aging." Annals of clinical and translational neurology vol. 2,6 (2015): 688-98. doi: https://doi.org/10.1002/acn3.204
Hayes SM, Salat DH, Forman DE, Sperling RA, Verfaellie M. Cardiorespiratory fitness is associated with white matter integrity in aging. Ann Clin Transl Neurol. 2015 Jun;2(6):688-98. doi: 10.1002/acn3.204. Epub 2015 Apr 24. PMID: 26125043; PMCID: PMC4479528.
Copy Download .nbib Format: NLM
Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?.

Neurodegenerative disease management

Marshall GA, Amariglio RE, Sperling RA, Rentz DM.
PMID: 23585777
Neurodegener Dis Manag. 2012 Oct 01;2(5):483-491. doi: 10.2217/nmt.12.55.

Impairment in activities of daily living (ADL) accompanies cognitive and behavioral symptoms in Alzheimer's disease (AD). Conventionally, ADL impairment has been relegated to the stage of dementia, but instrumental ADL impairment has been shown to occur earlier at the...

Cite
Marshall GA, Amariglio RE, Sperling RA, et al. Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?. Neurodegener Dis Manag. 2012;2(5):483-491doi: 10.2217/nmt.12.55.
Marshall, G. A., Amariglio, R. E., Sperling, R. A., & Rentz, D. M. (2012). Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?. Neurodegenerative disease management, 2(5), 483-491. https://doi.org/10.2217/nmt.12.55
Marshall, Gad A, et al. "Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?." Neurodegenerative disease management vol. 2,5 (2012): 483-491. doi: https://doi.org/10.2217/nmt.12.55
Marshall GA, Amariglio RE, Sperling RA, Rentz DM. Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?. Neurodegener Dis Manag. 2012 Oct 01;2(5):483-491. doi: 10.2217/nmt.12.55. PMID: 23585777; PMCID: PMC3622716.
Copy Download .nbib Format: NLM
Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study.

Alzheimer's & dementia (Amsterdam, Netherlands)

Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE.
PMID: 31673597
Alzheimers Dement (Amst). 2019 Sep 25;11:670-678. doi: 10.1016/j.dadm.2019.08.004. eCollection 2019 Dec.

INTRODUCTION: We aimed to examine the contribution of subjective cognitive decline (SCD) to reduce the number of β-amyloid (Aβ) positron emission tomography scans required for recruiting Aβ+ clinically normal individuals in clinical trials.METHODS: Three independent cohorts (890 clinically normal:...

Cite
Buckley RF, Sikkes S, Villemagne VL, et al. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimers Dement (Amst). 2019;11:670-678doi: 10.1016/j.dadm.2019.08.004.
Buckley, R. F., Sikkes, S., Villemagne, V. L., Mormino, E. C., Rabin, J. S., Burnham, S., Papp, K. V., Doré, V., Masters, C. L., Properzi, M. J., Schultz, A. P., Johnson, K. A., Rentz, D. M., Sperling, R. A., & Amariglio, R. E. (2019). Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimer's & dementia (Amsterdam, Netherlands), 11670-678. https://doi.org/10.1016/j.dadm.2019.08.004
Buckley, Rachel F, et al. "Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 11 (2019): 670-678. doi: https://doi.org/10.1016/j.dadm.2019.08.004
Buckley RF, Sikkes S, Villemagne VL, Mormino EC, Rabin JS, Burnham S, Papp KV, Doré V, Masters CL, Properzi MJ, Schultz AP, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study. Alzheimers Dement (Amst). 2019 Sep 25;11:670-678. doi: 10.1016/j.dadm.2019.08.004. eCollection 2019 Dec. PMID: 31673597; PMCID: PMC6816447.
Copy Download .nbib Format: NLM
Establishing Clinical Relevance in Preclinical Alzheimer's Disease.

The journal of prevention of Alzheimer's disease

Sperling RA, Amariglio RE, Marshall GA, Rentz DM.
PMID: 26247003
J Prev Alzheimers Dis. 2015 Jun;2(2):85-87. doi: 10.14283/jpad.2015.56.

No abstract available.

Cite
Sperling RA, Amariglio RE, Marshall GA, et al. Establishing Clinical Relevance in Preclinical Alzheimer's Disease. J Prev Alzheimers Dis. 2015;2(2):85-87doi: 10.14283/jpad.2015.56.
Sperling, R. A., Amariglio, R. E., Marshall, G. A., & Rentz, D. M. (2015). Establishing Clinical Relevance in Preclinical Alzheimer's Disease. The journal of prevention of Alzheimer's disease, 2(2), 85-87. https://doi.org/10.14283/jpad.2015.56
Sperling, R A, et al. "Establishing Clinical Relevance in Preclinical Alzheimer's Disease." The journal of prevention of Alzheimer's disease vol. 2,2 (2015): 85-87. doi: https://doi.org/10.14283/jpad.2015.56
Sperling RA, Amariglio RE, Marshall GA, Rentz DM. Establishing Clinical Relevance in Preclinical Alzheimer's Disease. J Prev Alzheimers Dis. 2015 Jun;2(2):85-87. doi: 10.14283/jpad.2015.56. PMID: 26247003; PMCID: PMC4523117.
Copy Download .nbib Format: NLM
Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults.

Molecular psychiatry

Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJ.
PMID: 30538309
Mol Psychiatry. 2020 Oct;25(10):2644. doi: 10.1038/s41380-018-0323-y.

This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.

Cite
Hanseeuw BJ, Jonas V, Jackson J, et al. Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry. 2020;25(10):2644doi: 10.1038/s41380-018-0323-y.
Hanseeuw, B. J., Jonas, V., Jackson, J., Betensky, R. A., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Donovan, N. J. (2020). Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Molecular psychiatry, 25(10), 2644. https://doi.org/10.1038/s41380-018-0323-y
Hanseeuw, Bernard J, et al. "Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults." Molecular psychiatry vol. 25,10 (2020): 2644. doi: https://doi.org/10.1038/s41380-018-0323-y
Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry. 2020 Oct;25(10):2644. doi: 10.1038/s41380-018-0323-y. PMID: 30538309; PMCID: PMC7609262.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries